These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9198218)

  • 21. Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
    Nitu-Whalley IC; Griffioen A; Harrington C; Lee CA
    Am J Hematol; 2001 Apr; 66(4):280-4. PubMed ID: 11279640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New treatment for von Willebrand disease.
    Belavic JM
    Nurse Pract; 2010 Sep; 35(9):13-4. PubMed ID: 20720463
    [No Abstract]   [Full Text] [Related]  

  • 23. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
    Frank RD; Kunz D; Wirtz DC
    Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of the utility of desmopressin (1-deamino-8-D-arginine vasopressin) trials in the management of patients with von Willebrand disorder.
    Shortt J; Opat SS; Gorniak MB; Aumann HA; Collecutt MF; Street AM
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e181-3. PubMed ID: 19016919
    [No Abstract]   [Full Text] [Related]  

  • 25. Von Willebrand disease.
    Shearin-Patterson T; Davidson EJ
    JAAPA; 2013 Apr; 26(4):46. PubMed ID: 23610837
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery in subjects with von Willebrand disease.
    Rivard GE; Aledort L;
    Haemophilia; 2008 Mar; 14(2):271-5. PubMed ID: 18194310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant von Willebrand factor: a first-of-its-kind product for von Willebrand disease.
    Singal M; Kouides PA
    Drugs Today (Barc); 2016 Dec; 52(12):653-664. PubMed ID: 28276537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulated release of VWF and FVIII and the biologic implications.
    Haberichter SL; Shi Q; Montgomery RR
    Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand].
    Vicente V; Alberca I; Moraleda JM; López Borrasca A
    Sangre (Barc); 1983; 28(4):531-2. PubMed ID: 6606856
    [No Abstract]   [Full Text] [Related]  

  • 30. The diagnosis and management of von Willebrand disease in Canada.
    James PD; Lillicrap DP
    Semin Thromb Hemost; 2011 Jul; 37(5):522-7. PubMed ID: 22102195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. von Willebrand disease: from the bedside to therapy.
    Aledort LM
    Thromb Haemost; 1997 Jul; 78(1):562-5. PubMed ID: 9198216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of von Willebrand disease after liver transplantation.
    Schulman S; Ericzon BG; Eleborg L
    Thromb Haemost; 2001 Dec; 86(6):1588-9. PubMed ID: 11776336
    [No Abstract]   [Full Text] [Related]  

  • 34. 1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease.
    Hanna WT; Slywka J; Dent J; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1985 Oct; 20(2):169-73. PubMed ID: 3929596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII?
    Drillaud N; Ardillon L; Ternisien C; Valentin JB; Fouassier M; Gillet B; Gruel Y; Sigaud M; Horvais V; Bene MC; Trossaërt M
    Transfus Med Rev; 2020 Apr; 34(2):128-129. PubMed ID: 31813707
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of single factor deficiencies: a case study approach.
    Marques MB
    Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193
    [No Abstract]   [Full Text] [Related]  

  • 38. von Willebrand disease in the 21st century: current approaches and new challenges.
    Mannucci PM; Federici AB; James AH; Kessler CM
    Haemophilia; 2009 Sep; 15(5):1154-8. PubMed ID: 19624761
    [No Abstract]   [Full Text] [Related]  

  • 39. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 40. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.